Quang X Pham, Chairman, CEO and Interim CFO at Cadrenal Therapeutics, sold CVKD on Jun 22, 2026
Data as of Oct 27
▼ SELL$32.5K9,167 shares at $3.55Quang X Pham Chairman, CEO and Interim CFOCVKD Cadrenal Therapeutics, Inc.
- Traded
- Jun 22, 2026
- Disclosed
- Jun 24, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
CVKD since disclosure
−68.4%
after the sale
Similar stocks (XLV) since disclosure
+16.8%
XLV — its sector index fund
Change in closing price from Jun 24, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLQuang X Pham Chairman, CEO and Interim CFOCVKD Cadrenal Therapeutics, Inc.$7.3Kdisclosed Jun 24 · filed 1 day after the trade